HIV-1 associated cognitive/motor complex in an injecting drug user.
The clinical and social consequences of AIDS dementia complex/HIV-1 associated cognitive/motor complex (ADC/HACC) in drug users have not been well documented. The value of prospective serial neuropsychological, neuroradiological and neurophysiological measurements to assist diagnosis of ADC/HACC in patients with premorbid personality disorder and intercurrent drug use is demonstrated. The psychosocial problems resulting from ADC/HACC with respect to community care and the location of hospitalization is considered. The relevance of the 1984 Mental Health Act (Scotland) with regard to drug users with ADC/HACC is discussed.
Maxwell
J
J
Infectious Diseases Unit, King's Cross Hospital, Dundee, Scotland, UK.
Egan
V
V
Chiswick
A
A
Burns
S
S
Gordon
A
A
Kean
D
D
Brettle
R P
RP
Pullen
I
I
D015526:AIDS Dementia Complex / Q000175:diagnosis* / Q000473:pathology / Q000523:psychology; D000328:Adult; D001921:Brain / Q000473:pathology; D016057:Evoked Potentials, Auditory, Brain Stem / Q000502:physiology; D005911:Gliosis / Q000473:pathology; D015497:HIV-1; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009460:Neurologic Examination; D009483:Neuropsychological Tests; D011596:Psychomotor Disorders / Q000175:diagnosis* / Q000473:pathology / Q000523:psychology; D011619:Psychotropic Drugs / Q000009:adverse effects; D015819:Substance Abuse, Intravenous / Q000150:complications
D011619:Psychotropic Drugs